The ascension of copyright’s drug initially fueled significant growth in the pharmaceutical sector, creating a image of substantial gains. However, placing capital in companies heavily reliant on flagship drugs like https://lilynbof094990.acidblog.net/72350937/the-blue-pill-and-the-pharmaceutical-industry-a-risky-investment